Dr. Haitham Amal received his B.Sc.Pharm degree from the Pharmacy School, Faculty of Medicine, at the Hebrew University in Jerusalem in 2007. He received his M.Sc. in Neuroscience and Pharmacology from the Faculty of Medicine, Tel-Aviv university in 2009. In 2015, he completed his Ph.D. entitled "The Unique Chemical Signature Of Cancer In Exhaled Breath" from the Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, Technion, Haifa, Israel under the supervision of Prof. Hossam Haick. His Ph.D. research was supported by several fellowship including The Council for Higher Education fellowship; Ministry of Science, Technology, and Space travel Grant; Merit Award from ISOBM, Research Excellence Award by the Technion. He has lectured in Pharmacology for the TEAMS program in the Medical school in the Technion and was teaching assistant in the Nano_Sensors course.

Currently, Haitham is a Postdoctoral Fellow at MIT in the Department of Biological Engineering in the Tannenbaum lab, supported by the MIT-TECHNION Postdoctoral fellowship and the Council for Higher Education Postdoctoral Fellowship.

He is working on several projects at MIT in collaboration with the McGovern Institute, Broad Institute and the Mechanical Engineering Department. He is using different OMICS techniques to understand the mechanisms and pathological signaling pathways and trafficking processes of several neurological disorders such as autism and Alzheimer's disease. Haitham is also involved in the DARPA, "Body On A Chip" project with the objective of integrating cells from ten different human organs on one device; if successful, this project will deliver a novel way for the research/industrial community to have a model human physiome that can be translated to biopharmaceutical research.